Keyphrases
Neuropathy
100%
Cisplatin
100%
Amifostine
100%
Related Compounds
100%
Vitamin E
87%
Quantitative Sensory Testing
87%
Neurotoxicity
75%
Magnesium
75%
Glutathione
62%
Diethyldithiocarbamate
62%
Meta-analysis
50%
Retinoic Acid
50%
Oxcarbazepine
50%
Chemotherapy
37%
National Cancer Institute
37%
Common Toxicity Criteria
37%
Acetylcysteine
37%
Nerve Conduction Studies
37%
Chemoprotective Effect
37%
Subjective Measures
37%
Vibration Perception Threshold
37%
Placebo
25%
Cochrane
25%
Neuroprotection
25%
Human Patients
25%
Review Authors
25%
Primary Outcome Measure
25%
Neuroprotective Agents
25%
Neurological Impairment
12%
High Risk
12%
Disease Groups
12%
Drug Use
12%
Solid Tumors
12%
Randomized Controlled Trial
12%
Randomized Trial
12%
Adverse Events
12%
MEDLINE
12%
Risk of Bias
12%
Selection Criteria
12%
Embase
12%
Search Methods
12%
Adrenocorticotropic Hormone
12%
Post-treatment Evaluation
12%
March 2013
12%
Risk Reduction
12%
Cisplatin-based Chemotherapy
12%
Number of Participants
12%
Qualitative Measures
12%
Favorable Outcome
12%
Lilac
12%
Quasi-randomized Controlled Trial
12%
Neuromuscular Disease
12%
Neuroprotective Therapy
12%
Hypocalcemia
12%
N-acetylcysteine
12%
CINAHL
12%
Antineoplastic Drugs
12%
Grading Scale
12%
Sensory Neuropathy
12%
Impairment Rating
12%
Scale Validation
12%
BNP7787
12%
Methodological Heterogeneity
12%
Chemoprotectant
12%
Number of Trials
12%
Threshold Result
12%
Platin
12%
Platinum Drugs
12%
Quantitative Objectives
12%
Formal Review
12%
Estudy
12%
Transient Hypotension
12%
Nursing and Health Professions
Cisplatin
100%
Neuropathy
100%
Amifostine
100%
Alpha Tocopherol
87%
Neurotoxicity
75%
Glutathione
62%
Diethyldithiocarbamic Acid
62%
Meta Analysis
50%
Retinoic Acid
50%
Acetylcysteine
50%
2 Amino 4 (Methylsulfonyl)butyrylglutamylhistidylphenylalanyl Dextro Lysylphenylalanine
50%
Oxcarbazepine
50%
National Health Organization
37%
Perceptive Threshold
37%
Neuroprotective Agent
37%
Chemoprotective Agent
37%
Placebo
25%
Neuroprotection
25%
Hypotension
12%
Adverse Event
12%
Corticotropin
12%
Hypocalcaemia
12%
Neuromuscular Disease
12%
CINAHL
12%
Medline
12%
Anticarcinogen
12%
Embase
12%
Solid Malignant Neoplasm
12%
Sensory Neuropathy
12%
Dimesna
12%
Borderline State
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropathy
100%
Cisplatin
100%
Amifostine
100%
Alpha Tocopherol
87%
Neurotoxicity
75%
Glutathione
62%
Sodium Diethyldithiocarbamate
62%
Chemotherapy
50%
Retinoic Acid
50%
Acetylcysteine
50%
Oxcarbazepine
50%
2 Amino 4 (Methylsulfonyl)butyrylglutamylhistidylphenylalanyl Dextro Lysylphenylalanine
50%
Malignant Neoplasm
37%
Neuroprotective Agent
37%
Chemoprotective Agent
37%
Placebo
25%
Randomized Controlled Trial
25%
Neuroprotection
25%
Adverse Event
12%
Hypotension
12%
Solid Malignant Neoplasm
12%
Anticarcinogen
12%
Retrospective Study
12%
Corticotropin
12%
Sensory Neuropathy
12%
Neuromuscular Disease
12%
Dimesna
12%
Hypocalcaemia
12%
Borderline State
12%
Neuroscience
Peripheral Neuropathy
100%
Cisplatin
100%
Amifostine
100%
Vitamin E
87%
Quantitative Sensory Testing
87%
Neurotoxicity
75%
Glutathione
62%
Meta-Analysis
50%
Acetylcysteine
50%
Tretinoin
50%
Oxcarbazepine
50%
2 Amino 4 (Methylsulfonyl)butyrylglutamylhistidylphenylalanyl Dextro Lysylphenylalanine
50%
Neuroprotective Agent
37%
Chemoprotective Agent
37%
Placebo
25%
Randomized Controlled Trial
25%
Neuroprotection
25%
Nerve Conduction Study
25%
Neuromuscular Disorder
12%
Nerve Conduction
12%
Adrenocorticotropic Hormone
12%
Antineoplastic Drugs
12%
Food Science
Vitamin E
100%
Magnesium
85%
Glutathione
71%
Cysteine
14%
Descriptive Analysis
14%
Medicine and Dentistry
Diethyldithiocarbamic Acid
62%
2 Amino 4 (Methylsulfonyl)butyrylglutamylhistidylphenylalanyl Dextro Lysylphenylalanine
50%
Dimesna
12%
Chemoprotectant
12%